- Home
- BZFD vs CPIX Comparison
BZFD vs CPIX Comparison
Compare BZFD & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BZFD | CPIX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | 507 | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.5M | 98.3M |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | BZFD | CPIX |
|---|---|---|
| Price | $1.11 | $7.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 288.4K | 36.8K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.70 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $185,266,000.00 | $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $108.07 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.75 |
| 52 Week Low | $0.54 | $1.85 |
| 52 Week High | $2.21 | $9.28 |
Technical Indicators
Market Signals| Indicator | BZFD | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 48.38 | 46.63 |
| Support Level | $1.05 | $5.55 |
| Resistance Level | $1.16 | $7.36 |
| Average True Range (ATR) | 0.07 | 0.49 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 45.45 | 39.90 |
Price Performance
Historical ComparisonAbout BZFD BuzzFeed Inc.
BuzzFeed Inc is a digital media company across pop culture, entertainment, shopping, food, and news, its brands drive conversation and inspire what audiences watch, read, and buy now and into the future. Its iconic, globally-loved brands include BuzzFeed, HuffPost, and Tasty. The company generates revenue from advertising, content, commerce, and other sources.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.